Jonathan Colen DO FAPA
Psychopharmacology, Psychosomatic Medicine, Sleep Medicine
Adult Psychiatry
Join to view full profile
1600 W Walnut StFl 3Jacksonville, IL 62650
Phone+1 217-545-8000
Fax+1 217-479-5737
Dr. Colen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Missouri-ColumbiaChief Residency, Psychiatry, 2002 - 2003- University of Missouri-ColumbiaResidency, Psychiatry, 2001 - 2003
Sparrow Hospital/Michigan State UniversityResidency, Rotating Internship, 1994 - 1995
A. T. Still University Kirksville College of Osteopathic MedicineClass of 1994
Certifications & Licensure
IL State License 2003 - 2029
MO State License 1995 - 2027
MI State License 1996 - 1996
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Publications & Presentations
PubMed
- Interpreting Neural Operators: How Nonlinear Waves Propagate in Nonreciprocal Solids.Jonathan Colen, Alexis Poncet, Denis Bartolo, Vincenzo Vitelli
Physical Review Letters. 2024-09-06 - Motor crosslinking augments elasticity in active nematics.Steven A Redford, Jonathan Colen, Jordan L Shivers, Sasha Zemsky, Mehdi Molaei
Soft Matter. 2024-03-13 - 32 citationsMachine learning interpretable models of cell mechanics from protein images.Matthew S Schmitt, Jonathan Colen, Stefano Sala, John Devany, Shailaja Seetharaman
Cell. 2024-01-18
Grant Support
- Therapeutic enzyme depletion of L-serine for cancer treatmentUNIVERSITY OF TEXAS AT AUSTIN2023–2028
- Therapeutic enzyme depletion of L-serine for cancer treatmentUNIVERSITY OF TEXAS AT AUSTIN2023–2028
- Therapeutic enzyme depletion of L-serine for cancer treatmentUNIVERSITY OF TEXAS AT AUSTIN2023–2028
- Targeting Serine Auxotrophy in Luminal Breast CancerUNIVERSITY OF ILLINOIS AT CHICAGO2021–2028
- Targeting Serine Auxotrophy in Luminal Breast CancerUNIVERSITY OF ILLINOIS AT CHICAGO2021–2028
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
